Atopic Dermatitis Treatment Market - Global Industry Analysis and Opportunity Assessment, 2019-2029
A recent market study published by Future Market Insights (FMI) on the atopic dermatitis treatment includes global industry analysis 2014-2018 & opportunity assessment 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the atopic dermatitis treatment, the growth prospects of the market are obtained with maximum precision.
Chapter 01 – Executive Summary
The report initiates with the executive summary of the atopic dermatitis treatment, which includes a summary of key findings and statistics of the market. It also includes demand & supply-side trends pertaining to the atopic dermatitis treatment.
Chapter 02 – Market Overview
Readers can find the definition and a detailed segmentation of the atopic dermatitis treatment in this chapter, which will help them understand the basic information about the atopic dermatitis treatment.
Chapter 03 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the atopic dermatitis treatment over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
Chapter 04 – Market Context
This section includes the premium insights such as regulatory scenario, disease epidemiology and parent market analysis. This section helps readers understand the key factors associated with the atopic dermatitis treatment market.
Chapter 05 – Global Atopic Dermatitis Treatment Demand Analysis 2014-2018 & Opportunity Assessment 2019-2029
This section explains the global market value analysis and forecast for the atopic dermatitis treatment between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical atopic dermatitis treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).
Chapter 06 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Drug Class
Based on drug type, the atopic dermatitis treatment market is segmented into corticosteroids, calcineurin inhibitors, immunosuppressants, biologic therapy, PDE4 inhibitor, antibiotics, antihistamines, emollients. In this chapter, readers can find information about the key trends and developments in the atopic dermatitis treatment and market attractiveness analysis based on drug type.
Chapter 07 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Mode of Administration
This chapter provides details about the atopic dermatitis treatment based on mode of administration, and has been classified into oral, topical and injectable. In this chapter, readers can understand the market attractiveness analysis based on mode of administration.
Chapter 08 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel
This chapter provides details about the atopic dermatitis treatment market based on distribution channel, and has been classified into hospital pharmacies, retail pharmacies, online pharmacies, drug stores, mail order pharmacies, dermatological clinics. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.
Chapter 09 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region
This chapter explains how the atopic dermatitis treatment market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa (MEA).
Chapter 10 – North America Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter includes a detailed analysis of the growth of the North America atopic dermatitis treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.
Chapter 11 – Latin America Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter provides the growth scenario of atopic dermatitis treatment market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
Chapter 12 – Western Europe Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
Important growth prospects of the atopic dermatitis treatment market based on its end users in several countries such as Germany, the U.K., France, Spain, Italy, Russia, BENELUX, and the Rest of Europe are included in this chapter.
Chapter 13 – Eastern Europe Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
In this chapter, Russia, Poland & Rest of Eastern Europe countries are the prominent countries in the Eastern Europe region that are the prime subjects of assessment to obtain the growth prospects of the Eastern Europe atopic dermatitis treatment market. Readers can find detailed information about the growth parameters of the Eastern Europe atopic dermatitis treatment market during the forecast period of 2019-2029.
Chapter 14 – Asia pacific excluding Japan Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter highlights the growth of the atopic dermatitis treatment in Asia pacific excluding Japan by focusing on China, India, Australia & New Zealand, ASEAN and rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the atopic dermatitis treatment market in the APEJ region.
Chapter 15 – Japan Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter highlights the growth of the atopic dermatitis treatment in Japan. This section also help readers understand the key factors that are responsible for the growth of the atopic dermatitis treatment market in Japan.
Chapter 16 – MEA Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter provides information about how the atopic dermatitis treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, Turkey, Northern Africa and the Rest of MEA, during the forecast period of 2019-2029.
Chapter 17 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the atopic dermatitis treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Novartis, Bayer, Allergan, Sanofi and among others.
Chapter 18 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the atopic dermatitis treatment report.
Chapter 19 – Research Methodology
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the atopic dermatitis treatment.
- 1. Executive Summary
- 1.1. Market Outlook
- 1.2. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Macro-Economic Factors
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity Analysis
- 3.1.4. Trends
- 4. Market Context
- 4.1. Global Atopic Dermatitis Treatment Market Size (US$ Mn) and Forecast
- 4.2. Global Epidemiology of Atopic Dermatitis
- 4.3. Global Atopic Dermatitis Treatment Market Opportunity Analysis
- 4.4. Key Regulations and Guidelines
- 5. Global Atopic Dermatitis Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
- 5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
- 5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
- 5.2.1. Y-o-Y Growth Trend Analysis
- 5.2.2. Absolute $ Opportunity Analysis
- 5.2.3. Market Value Comparison
- 6. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2014-2018
- 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2019 - 2029
- 6.3.1. Corticosteroids
- 6.3.2. Calcineurin Inhibitors
- 6.3.3. Immunosuppressant
- 6.3.4. Biologic Therapy
- 6.3.5. PDE-4 Inhibitor
- 6.3.6. Antibiotics
- 6.3.7. Antihistamines
- 6.3.8. Emollients
- 6.4. Market Attractiveness Analysis By Drug Class
- 7. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Mode of Administration
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size (US$ Mn) Analysis By Mode of Administration, 2014-2018
- 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode of Administration, 2019 - 2029
- 7.3.1. Topical
- 7.3.2. Oral
- 7.3.3. Injectable
- 7.4. Market Attractiveness Analysis By Mode of Administration
- 8. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
- 8.3.1. Hospital Pharmacies
- 8.3.2. Retail Pharmacies
- 8.3.3. Online Pharmacies
- 8.3.4. Drug Stores
- 8.3.5. Mail Order Pharmacies
- 8.3.6. Dermatology Clinics
- 8.4. Market Attractiveness Analysis By Distribution Channel
- 9. Global Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region Type
- 9.1. Introduction
- 9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
- 9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
- 9.3.1. North America
- 9.3.2. Latin America
- 9.3.3. Western Europe
- 9.3.4. Eastern Europe
- 9.3.5. Asia-Pacific Excluding Japan
- 9.3.6. Japan
- 9.3.7. Middle East and Africa
- 9.4. Market Attractiveness Analysis By Region
- 10. North America Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
- 10.1. Introduction
- 10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
- 10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
- 10.3.1. By Country
- 10.3.1.1. U.S.
- 10.3.1.2. Canada
- 10.3.2. By Drug Class
- 10.3.3. By Mode of Administration
- 10.3.4. By Distribution Channel
- 10.4. Market Attractiveness Analysis
- 10.4.1. By Country
- 10.4.2. By Drug Class
- 10.4.3. By Mode of Administration
- 10.4.4. By Distribution Channel
- 11. Latin America Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
- 11.1. Introduction
- 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
- 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
- 11.3.1. By Country
- 11.3.1.1. Mexico
- 11.3.1.2. Brazil
- 11.3.1.3. Rest of Latin America
- 11.3.2. By Drug Class
- 11.3.3. By Mode of Administration
- 11.3.4. By Distribution Channel
- 11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Drug Class
- 11.4.3. By Mode of Administration
- 11.4.4. By Distribution Channel
- 12. Western Europe Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
- 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
- 12.3.1. By Country
- 12.3.1.1. Germany
- 12.3.1.2. Italy
- 12.3.1.3. France
- 12.3.1.4. U.K.
- 12.3.1.5. Spain
- 12.3.1.6. BENELUX
- 12.3.1.7. Nordic
- 12.3.1.8. Rest of Western Europe
- 12.3.2. By Drug Class
- 12.3.3. By Mode of Administration
- 12.3.4. By Distribution Channel
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Drug Class
- 12.4.3. By Mode of Administration
- 12.4.4. By Distribution Channel
- 13. Eastern Europe Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
- 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
- 13.3.1. By Country
- 13.3.1.1. Germany
- 13.3.1.2. Italy
- 13.3.1.3. France
- 13.3.1.4. U.K.
- 13.3.1.5. Spain
- 13.3.1.6. BENELUX
- 13.3.1.7. Nordic
- 13.3.1.8. Rest of Western Europe
- 13.3.2. By Drug Class
- 13.3.3. By Mode of Administration
- 13.3.4. By Distribution Channel
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Drug Class
- 13.4.3. By Mode of Administration
- 13.4.4. By Distribution Channel
- 14. APEJ Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
- 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
- 14.3.1. By Country
- 14.3.1.1. China
- 14.3.1.2. India
- 14.3.1.3. Australia & New Zealand
- 14.3.1.4. ASEAN
- 14.3.1.5. Rest of APEJ
- 14.3.2. By Drug Class
- 14.3.3. By Mode of Administration
- 14.3.4. By Distribution Channel
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Drug Class
- 14.4.3. By Mode of Administration
- 14.4.4. By Distribution Channel
- 15. Japan Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
- 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
- 15.3.1. By Drug Class
- 15.3.2. By Mode of Administration
- 15.3.3. By Distribution Channel
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Drug Class
- 15.4.2. By Mode of Administration
- 15.4.3. By Distribution Channel
- 16. Middle East and Africa Atopic Dermatitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
- 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
- 16.3.1. By Country
- 16.3.1.1. GCC Countries
- 16.3.1.2. Northern Africa
- 16.3.1.3. South Africa
- 16.3.1.4. Turkey
- 16.3.1.5. Rest of MEA
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Drug Class
- 16.4.3. By Mode of Administration
- 17. Competition Analysis
- 17.1. Competition Dashboard
- 17.2. Competition Deep Dive
- 17.2.1. Sanofi S.A.
- 17.2.1.1. Overview
- 17.2.1.2. Product Portfolio
- 17.2.1.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.1.4. Sales Footprint
- 17.2.1.5. Strategy Overview
- 17.2.1.5.1. Marketing Strategy
- 17.2.1.5.2. Product Strategy
- 17.2.1.5.3. Mode of Administration Strategy
- 17.2.2. Galderma S.A
- 17.2.2.1. Overview
- 17.2.2.2. Product Portfolio
- 17.2.2.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.2.4. Sales Footprint
- 17.2.2.5. Strategy Overview
- 17.2.2.5.1. Marketing Strategy
- 17.2.2.5.2. Product Strategy
- 17.2.2.5.3. Mode of Administration Strategy
- 17.2.3. Allergan Plc.
- 17.2.3.1. Overview
- 17.2.3.2. Product Portfolio
- 17.2.3.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.3.4. Sales Footprint
- 17.2.3.5. Strategy Overview
- 17.2.3.5.1. Marketing Strategy
- 17.2.3.5.2. Product Strategy
- 17.2.3.5.3. Mode of Administration Strategy
- 17.2.4. Novartis AG
- 17.2.4.1. Overview
- 17.2.4.2. Product Portfolio
- 17.2.4.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.4.4. Sales Footprint
- 17.2.4.5. Strategy Overview
- 17.2.4.5.1. Marketing Strategy
- 17.2.4.5.2. Product Strategy
- 17.2.4.5.3. Mode of Administration Strategy
- 17.2.5. Bristol-Meyer Squibb
- 17.2.5.1. Overview
- 17.2.5.2. Product Portfolio
- 17.2.5.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.5.4. Sales Footprint
- 17.2.5.5. Strategy Overview
- 17.2.5.5.1. Marketing Strategy
- 17.2.5.5.2. Product Strategy
- 17.2.5.5.3. Mode of Administration Strategy
- 17.2.6. Bayer AG
- 17.2.6.1. Overview
- 17.2.6.2. Product Portfolio
- 17.2.6.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.6.4. Sales Footprint
- 17.2.6.5. Strategy Overview
- 17.2.6.5.1. Marketing Strategy
- 17.2.6.5.2. Product Strategy
- 17.2.6.5.3. Mode of Administration Strategy
- 17.2.7. Mylan Pharmaceuticals Inc.
- 17.2.7.1. Overview
- 17.2.7.2. Product Portfolio
- 17.2.7.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.7.4. Sales Footprint
- 17.2.7.5. Strategy Overview
- 17.2.7.5.1. Marketing Strategy
- 17.2.7.5.2. Product Strategy
- 17.2.7.5.3. Mode of Administration Strategy
- 17.2.8. Astellas Pharma Inc.
- 17.2.8.1. Overview
- 17.2.8.2. Product Portfolio
- 17.2.8.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.8.4. Sales Footprint
- 17.2.8.5. Strategy Overview
- 17.2.8.5.1. Marketing Strategy
- 17.2.8.5.2. Product Strategy
- 17.2.8.5.3. Mode of Administration Strategy
- 17.2.9. Anacor Pharmaceuticals, Inc.
- 17.2.9.1. Overview
- 17.2.9.2. Product Portfolio
- 17.2.9.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.9.4. Sales Footprint
- 17.2.9.5. Strategy Overview
- 17.2.9.5.1. Marketing Strategy
- 17.2.9.5.2. Product Strategy
- 17.2.9.5.3. Mode of Administration Strategy
- 17.2.10. Regeneron Pharmaceuticals, Inc.
- 17.2.10.1. Overview
- 17.2.10.2. Product Portfolio
- 17.2.10.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.10.4. Sales Footprint
- 17.2.10.5. Strategy Overview
- 17.2.10.5.1. Marketing Strategy
- 17.2.10.5.2. Product Strategy
- 17.2.10.5.3. Mode of Administration Strategy
- 17.2.11. Bausch Health Inc.
- 17.2.11.1. Overview
- 17.2.11.2. Product Portfolio
- 17.2.11.3. Profitability by Market Segments (Product/Mode of Administration/Region)
- 17.2.11.4. Sales Footprint
- 17.2.11.5. Strategy Overview
- 17.2.11.5.1. Marketing Strategy
- 17.2.11.5.2. Product Strategy
- 17.2.11.5.3. Mode of Administration Strategy
- 18. Assumptions and Acronyms Used
- 19. Research Methodology
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook